State Street Corp Precigen, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Precigen, Inc. stock. As of the latest transaction made, State Street Corp holds 3,029,100 shares of PGEN stock, worth $5.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,029,100
Previous 3,038,127
0.3%
Holding current value
$5.45 Million
Previous $4.53 Million
4.97%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding PGEN
# of Institutions
164Shares Held
164MCall Options Held
516KPut Options Held
964K-
Third Security, LLC83.5MShares$150 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD16.3MShares$29.3 Million1.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$20.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$18.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$16.3 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $375M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...